AST 120 clinical trials

Studies by the year they started

18 studies that test it; most in 2007 (7)

Who runs them

Industry 12 · Other 6

Ocera Therapeutics (7) · Tanabe Pharma Corporation (2) · Astellas Pharma Inc (2) · Chang Gung Memorial Hospital (2) · Conmed Pharmaceutical & Bio-Medical Corporation (1) · Tungs' Taichung Metroharbour Hospital (1) · Seoul National University Hospital (1) · Institute for Health Outcomes and Process Evaluation Reseach (1)

Often tested with

Tested in the same studies.

Charcoal (18) · Roxadustat (1) · Beraprost (1)

Studies

Open first, then newest update. How each study uses AST 120 is read from its arms, and is right about nine times in ten.

Testing it · 18

• AST-120 (Kremezin®) for the Renal Protection and Attenuation of Decline in Acute Kidney DiseaseRecruitingPhase 4Chang Gung Memorial HospitalNCT07182422Written as AST-120 (Kremezin®)
• A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1)CompletedPhase 3Tanabe Pharma CorporationNCT00500682Written as AST-120
• A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)CompletedPhase 3Tanabe Pharma CorporationNCT00501046Written as AST-120
• AST-120 in Hemodialysis Patients With Uremic PruritusCompletedPhase 4Conmed Pharmaceutical & Bio-Medical CorporationNCT04639674Written as AST-120
• Pharmacokinetic Study of ASP1517 With Kremezin®CompletedPhase 1Astellas Pharma IncNCT02693613Written as Kremezin®
• Safety and Efficacy of AST-120 in the Treatment of PouchitisCompletedPhase 2Ocera TherapeuticsNCT00583076Written as AST-120
• Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel SyndromeCompletedPhase 2Ocera TherapeuticsNCT00583128Written as AST-120
• AST-120 Used to Treat Mild Hepatic EncephalopathyCompletedPhase 2Ocera TherapeuticsNCT00867698Written as AST-120
• Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory PouchitisTerminatedPhase 2Ocera TherapeuticsNCT00583531Written as AST-120
• Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPITerminatedPhase 2Ocera TherapeuticsNCT00587275Written as AST-120
• Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With FistulasCompletedPhase 3Ocera TherapeuticsNCT00321412Written as AST-120
• Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic EncephalopathyCompletedPhase 2Ocera TherapeuticsNCT00558038Written as AST-120
• Effect of Replacement Volume of Haemodiafiltration and AST-120 on Toxins, Oxidative Stress and MicroInflammationCompletedPhase 4Tungs' Taichung Metroharbour HospitalNCT01458652Written as Kremezin
• Kremezin Study Against Renal Disease Progression in KoreaCompletedPhase 4Seoul National University HospitalNCT00860431Written as AST-120
• Effect of An Oral Absorbent AST-120 in Late-stage Chronic Kidney Disease (CKD) Patients.CompletedPhase 4Chang Gung Memorial HospitalNCT01681303Written as AST-120
• The Effects of AST-120 on Endothelial Dysfunction in Patients With Chronic Kidney DiseaseStatus unknownPhase 4Ewha Womans UniversityNCT01157260Written as Kremezin
• Drug-Drug Interaction Study of TRK-100STPCompletedPhase 1Astellas Pharma IncNCT00719758Written as AST-120 (Kremezin®)
• Carbonaceous Oral Adsorbent's Effects on Progression of Chronic Kidney DiseaseCompletedPhase 4Institute for Health Outcomes and Process Evaluation ReseachNCT00456859Written as Kremezin

Codes

What other systems call AST 120 · ClinicalTrials.gg INT003137

• MeSH (NLM) C040896AST 120One source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.